Impact of Rosuvastatin on Contrast-Induced Acute Kidney Injury in Patients at High Risk for Nephropathy Undergoing Elective Angiography

American Journal of Cardiology

Volumn 115, Issue 7, 2015, Pages 867-871

  Abaci, Okay ^a   Arat Ozkan, Alev ^a   Kocas, Cuneyt ^a   Cetinkal, Gokhan ^a   Sukru Karaca, Osman ^a   Baydar, Onur ^a   Kaya, Aysem ^a   Gurmen, Tevfik ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; ROSUVASTATIN; CONTRAST MEDIUM; FLUOROBENZENE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRIMIDINE DERIVATIVE; SULFONAMIDE;

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; CREATININE BLOOD LEVEL; DEATH; DIALYSIS; DRUG EFFICACY; DRUG MEGADOSE; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FOLLOW UP; HEART INFARCTION; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; KIDNEY FAILURE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENAL PROTECTION; TREATMENT OUTCOME; ACUTE CORONARY SYNDROME; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; ANGIOCARDIOGRAPHY; CHEMICALLY INDUCED; DIAGNOSTIC USE; DRUG EFFECTS; GLOMERULUS FILTRATION RATE; PATHOPHYSIOLOGY; PROCEDURES; PROGNOSIS; RADIOGRAPHY; RETROSPECTIVE STUDY; RISK FACTOR;

ACUTE CORONARY SYNDROME; ACUTE KIDNEY INJURY; AGED; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; FEMALE; FLUOROBENZENES; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; PROGNOSIS; PYRIMIDINES; RETROSPECTIVE STUDIES; RISK FACTORS; SULFONAMIDES;

EID: 84929508098     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.01.007     Document Type: Article

References (17)

1. 1 Patti, G., Ricottini, E., Nusca, A., Colonna, G., Pasceri, V., D'Ambrosio, A., Montinaro, A., Di Sciascio, G., Short-term, high-dose atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [Atorvastatin for Reduction of Myocardial Damage During Angioplasty–Contrast-Induced Nephropathy] trial. Am J Cardiol 108 (2011), 1–7.
2. 2 Patti, P., Nusca, A., Chello, M., Pasceri, V., D'Ambrosio, A., Vetrovec, G.W., Di Sciascio, G., Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention. Am J Cardiol 101 (2008), 279–285.
3. 3 Jo, S.H., Koo, B.K., Park, J.S., Kang, H.J., Cho, Y.S., Kim, Y.J., Youn, T.J., Chung, W.Y., Chae, I.H., Choi, D.J., Sohn, D.W., Oh, B.H., Park, Y.B., Choi, Y.S., Kim, H.S., Prevention of Radiocontrast-Medium–Induced Nephropathy Using Short-Term High-Dose Simvastatin in Patients With Renal Insufficiency Undergoing Coronary Angiography (PROMISS) trial—a randomized controlled study. Am Heart J 155:suppl (2008), 499.e1–499.e8.
4. 4 Quintavalle, C., Fiore, D., De Micco, F., Visconti, G., Focaccio, A., Golia, B., Ricciardelli, B., Donnarumma, E., Bianco, A., Zabatta, M.A., Troncone, G., Colombo, A., Briguori, C., Condorelli, G., Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury. Circulation 126 (2012), 3008–3016.
5. 5 Pappy, R., Stavrakis, S., Hennebry, T.A., Abu-Fadel, M.S., Effect of statin therapy on contrast-induced nephropathy after coronary angiography: a meta-analysis. Int J Cardiol 151 (2011), 348–353.
6. 6 Leoncini, M., Toso, A., Maioli, M., Tropeano, F., Villani, S., Bellandi, F., Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Acute Kidney Injury and Myocardial Damage in Patients With Acute Coronary Syndrome). J Am Coll Cardiol 63 (2014), 71–79.
7. 7 KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:2 suppl 1 (2002), S1–S266.
8. 8 Windecker, S., Kolh, P., Alfonso, F., Collet, J.P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., Head, S.J., Jüni, P., Kappetein, A.P., Kastrati, A., Knuuti, J., Landmesser, U., Laufer, G., Neumann, F.J., Richter, D.J., Schauerte, P., Sousa Uva, M., Stefanini, G.G., Taggart, D.P., Torracca, L., Valgimigli, M., Wijns, W., Witkowski, A., 2014 ESC/EACTS guidelines on myocardial revascularization: the Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 35 (2014), 2541–2619.
9. 9 Mehran, R., Aymong, E.D., Nikolsky, E., Lasic, Z., Iakovou, I., Fahy, M., Mintz, G.S., Lansky, A.J., Moses, J.W., Stone, G.W., Leon, M.B., Dangas, G., A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44 (2004), 1393–1399.
10. 10 Spargias, K., Alexopoulos, E., Kyrzopoulos, S., Iokovis, P., Greenwood, D.C., Manginas, A., Voudris, V., Pavlides, G., Buller, C.E., Kremastinos, D., Cokkinos, D.V., Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 110 (2004), 2837–2842.
11. 11 McCullough, P.A., Contrast-induced acute kidney injury. J Am Coll Cardiol 51 (2008), 1419–1428.
12. 12 Tumlin, J., Stacul, F., Adam, A., Becker, C.R., Davidson, C., Lameire, N., McCullough, P.A., on behalf of the CIN Consensus Working Panel. Pathophysiology of contrast-induced nephropathy. Am J Cardiol 98 (2006), 14K–20K.
13. 13 Ruparelia, N., Digby, J.E., Jefferson, A., Medway, D.J., Neubauer, S., Lygate, C.A., Choudhury, R.P., Myocardial infarction causes inflammation and leukocyte recruitment at remote sites in the myocardium and in the renal glomerulus. Inflamm Res 62 (2013), 515–525.
14. 14 Xinwei, J., Xianghua, F., Jing, Z., Xinshun, G., Ling, X., Weize, F., Guozhen, H., Yunfa, J., Weili, W., Shiqiang, L., Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Am J Cardiol 104 (2009), 519–524.
15. 15 Li, Y., Liu, Y., Fu, L., Mei, C., Dai, B., Efficacy of short-term high-dose statin in preventing contrast-induced nephropathy: a meta-analysis of seven randomized controlled trials. PLoS One 7 (2012), 344–350.
16. 16 Toso, A., Maioli, M., Leoncini, M., Gallopin, M., Tedeschi, D., Micheletti, C., Manzone, C., Amato, M., Bellandi, F., Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease. Am J Cardiol 105 (2010), 288–292.
17. 17 Bartholomew, B.A., Harjai, K.J., Dukkipati, S., Boura, J.A., Yerkey, M.W., Glazier, S., Grines, C.L., O'Neill, W.W., Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 93 (2004), 1515–1519.